Related Experiment Video
Updated: Jun 3, 2026

Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia (SCG)
Published on: January 30, 2009
MKK7γ1 reverses nerve growth factor signals: proliferation and cell death instead of neuritogenesis and protection
Wiebke Haeusgen1, Thomas Herdegen, Vicki Waetzig
1Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Hospitalstrasse 4, 24105 Kiel, Germany.
Abstract:
c-Jun N-terminal kinases (JNKs) are the exclusive downstream substrates of mitogen-activated protein kinase kinase 7 (MKK7). Recently, we have shown that a single MKK7 splice variant, MKK7γ1, substantially changes the functions of JNKs in naïve PC12 cells. Here we provide evidence that MKK7γ1 blocks NGF-mediated differentiation and sustains proliferation by interfering with the NGF-triggered differentiation programme at several levels: (i) down-regulation of the NGF receptors TrkA and p75; (ii) attenuation of the differentiation-promoting pathways ERK1/2 and AKT; (iii) increase of JNK1 and JNK2, especially the JNK2 54kDa splice variants; (iv) repression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1), which normally supports NGF-mediated cell cycle arrest; (v) strong induction of the cell cycle promoter CyclinD1, and (vi) profound changes of p53 functions. Moreover, MKK7γ1 substantially changes the responsiveness to stress. Whereas NGF differentiation protects PC12 cells against taxol-induced apoptosis, MKK7γ1 triggers an escape from cell cycle arrest and renders transfected cells sensitive to taxol-induced death. This stress response completely differs from naïve PC12 cells, where MKK7γ1 protects against taxol-induced cell death. These novel aspects on the regulation of JNK signalling emphasise the importance of MKK7γ1 in its ability to reverse basic cellular programmes by simply using JNKs as effectors. Furthermore, our results highlight the necessity for the cells to balance the expression of JNK activators to ensure precise intracellular processes.
Insights
The MKK7γ1 splice variant reverses cellular programs by altering JNK signaling, blocking NGF-induced differentiation, and changing stress responses in PC12 cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Signaling Pathways
Background:
- c-Jun N-terminal kinases (JNKs) are key downstream targets of mitogen-activated protein kinase kinase 7 (MKK7).
- A specific MKK7 splice variant, MKK7γ1, was previously shown to alter JNK functions in PC12 cells.
Purpose of the Study:
- To investigate how MKK7γ1 influences NGF-mediated differentiation and proliferation.
- To elucidate the impact of MKK7γ1 on cellular stress responses.
Main Methods:
- Analysis of NGF receptor expression (TrkA, p75).
- Assessment of key signaling pathways (ERK1/2, AKT).
- Evaluation of cell cycle regulators (p21, CyclinD1) and p53 function.
- Investigation of taxol-induced apoptosis and cell cycle arrest.
Main Results:
- MKK7γ1 inhibits NGF-driven differentiation by down-regulating TrkA/p75 and attenuating ERK1/2/AKT pathways.
- MKK7γ1 increases specific JNK splice variants (JNK2 54kDa) and represses p21 while inducing CyclinD1, promoting proliferation.
- MKK7γ1 alters stress response, causing sensitivity to taxol-induced death, contrasting with protection in naïve cells.
Conclusions:
- MKK7γ1 profoundly reverses fundamental cellular programs, including differentiation and stress response, by manipulating JNK signaling.
- Balancing JNK activator expression is crucial for precise intracellular processes.
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Mitogens and the Cell Cycle
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
